Immediate and sustained terminal complement inhibition with ravulizumab in patients with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
- Ortiz, S.
- Pittock, S.J.
- Berthele, A.
- Levy, M.
- Nakashima, I.
- Oreja-Guevara, C.
- Allen, K.
- Mashhoon, Y.
- Parks, B.
- Kim, H.J.
Revista:
Frontiers in Neurology
ISSN: 1664-2295
Ano de publicación: 2024
Volume: 15
Tipo: Artigo